
The Multi-omics Data Science Research Group is focused on developing advanced computational and statistical methods of biomedical data analysis and interpretation.
The Multi-omics Data Science Group mainly focuses on the data obtained in cancer biology with high-throughput molecular profiling. We focus on extracting relevant biological signals and predictive features from tumors and surrounding tissues on various modalities: DNA methylation, RNA expression, protein abundance, and tissue histopathological images. Integrating the corresponding data improves our understanding of cancers and leads to better patient stratification and treatment. A special interest of the group is in contribution to translationally-oriented research through strong collaborations at the LIH, LNS and abroad. Members of the team enable cross-disciplinary research partnerships, which benefit from their diverse expertise in biostatistics, large-scale analysis and integration of multi-omics data, machine learning and scientific programming.
Petr Nazarov leads the Multi-omics Data Science research group at Luxembourg Institute of Health and is an invited Assistant Professor at Luxembourg University. He graduated as a physicist from Belarus State University in 2000 and got his PhD in biophysics at Wageningen University in 2006. Since then he has been working at Luxembourg Institute of Health as a postdoc, researcher and, finally, a group leader. His primary expertise lies in biostatistics, data analysis, machine learning and genomics. His works are mainly focused on analysis of cancer transcriptomes. He has a special interest in the deconvolution of transcriptomic and epigenomic signals from heterogeneous tumors.
The group members led or contributed to the following research projects:
Within the Luxembourg Institute of Health, qualified professionals with various expertises are working together striving for excellence. Their talent, their ability to collaborate and the complementarity of their skills are some of the key elements allowing us to create societal and economical value.
LIH researchers strive to generate meaningful and disease-relevant knowledge and results for patients. Their findings are regularly published in prestigious international peer-reviewed journals, thereby extending the reach and visibility of the institute’s impact.
